Cardiology
A study has explored how Halloween habits may impact heart health, offering insights for clinicians and public awareness.
Patients with KF and AF who received LAAO showed lower risks of death and bleeding compared with those treated with OACs.
An article shared how primary care clinicians can screen for and manage CVD throughout the breast cancer care continuum.
ARPIs used in combination with ADT in prostate cancer significantly increased the risk for cardiovascular events.
Lorundrustat reduces blood pressure in patients with uncontrolled, resistant hypertension, but careful monitoring is needed.
Robert Eckel, MD, and Janani Rangaswami, MD, explore the evolving landscape of combination therapies for CKM diseases.
Acute normovolemic hemodilution lowered the likelihood of transfusion by 27% in adult cardiac surgery.
Adding sotatercept to background therapy lowered the risk for clinical worsening in early PAH.
Across age groups and education levels, the burden of chronic kidney disease due to hypertension has risen since 1990.
Rates of transient ischemic attack, mitral valve stenosis, and heart failure declined after parathyroidectomy for pHPT.
Baxdrostat reduced blood pressure an average 8.1 mm Hg versus placebo in those with CKD and treatment-resistant hypertension.
Emphysema on baseline LDCT for lung cancer screening predicted all-cause, COPD, and CVD mortality within 25 years.
Over 99% of people who suffered a first heart attack, stroke, or heart failure event had at least one risk factor beforehand.
The US age-adjusted mortality rate for kidney disease related to high blood pressure increased by 48% over the past 25 years.
A wearable, cuffless blood pressure device is capable of continuously measuring blood pressure over extended periods.
An article in the Journal of Psoriasis and Psoriatic Arthritis shared how to screen for and manage cardiovascular risk.
Robert Eckel, MD, and Janani Rangaswami, MD, discuss the urgent need for integrated care models addressing CKM diseases
Serial hs-cTnI kinetics predicted 30-day MACE risk for patients with chest pain in emergency departments.
Researchers found gender-affirming hormone therapy had potential effects on cardiac repolarization in transgender patients.
For older adults, the RSVpreF vaccine reduced hospitalizations for RSV-related respiratory tract disease.
180 Mount Airy Road Suite 205
Basking Ridge, NJ 07920
Connect
The content of this site is intended for healthcare professionals.
© 2025 Physician’s Weekly, a Formedics PropertyAny views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.